Share Twitter LinkedIn Facebook Email Nataliya Mar, MD, UC Irvine Health, talks about Erdafitinib & Enfortumab Reached FDA Drug Designation | Will be Available in Clinics Within a Few Years at MOASC 2018
MOASC Awards $25,000 Research Grant from AVEO Oncology to Dr. Peter Zang, MD of City of Hope 2025 Cary Presant, MD Investigator Award Prostate 4 Mins Read
Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment – Charles Link, MD Prostate 2 Mins Read